Gil J. Van Lunsen

Gil J. Van Lunsen, listed as senior executive, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Array Biopharma Inc, MACOM Technology Solutions Holdings, Inc. and ONEOK Partners LP. Over a trading history stretching from 14 August 2006 to 4 March 2022, the count stands at 68 filings.

In open-market terms, that means 3 purchases worth €72k on one side and 22 sales worth €3.6M on the other. Sales outweigh purchases by €3.5M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 15 share grants and 24 option exercises.

In size, the median ticket on the buying side is €21k.

On 8 March 2022 came the latest disclosure, a share grant in MACOM Technology Solutions Holdings, Inc. The last purchase on record was published on 2 March 2010, which is 6,095 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.